Multicentric validation of a rapid assay for heparin-induced thrombocytopenia with different specimen types.
Kolde HJ, Habrecht U, von Hesberg J, Panzer S, Seidel H, Bakchoul T, Sachs UJ
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of testing for HIT in serum, citrated whole blood, EDTA whole blood or citrated plasma using a LFI-HIT and comparing results to those obtained with other assays. Specimens were collected from patients with suspected HIT at 5 different medical centers using either Becton Dickinson tubes or Sarstedt tubes. One center included specimens from healthy volunteers, one center included EDTA anticoagulated whole blood specimens, and one center included serum specimens that had been frozen and thawed, and the authors cite unpublished data which determined that freezing had no effects on LFI-HIT results.
Summary of Findings
LFI-HIT results using citrated whole blood, citrated plasma, and EDTA anticoagulated whole blood were 93.6%, 96.7%, and 100% identical, respectively, to those obtained using serum. As expected, all specimen types from healthy volunteers were negative for HIT. The authors state that more false positive results were obtained using the ELISA and the particle gel immunoassay than the LFI-HIT. The LFI-HIT results agreed with the heparin-induced platelet aggregation assay (HIPA) results 92.7%, 92.9%, and 89.7% of the time for serum, plasma, and whole blood specimens, respectively. Specifically, citrated whole blood yielded more false negative results than the serum or plasma, and the authors do not recommend its use in the LFI-HIT assay.
Biospecimens
FluidBloodFluidPlasmaFluidSerumPreservation Types
None (Fresh)FrozenDiagnoses
NormalOther diagnosesPlatforms
GlycoproteinImmunoassayGlycoproteinELISACell count/volumeFlow cytometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition HealthySuspected HITPreaquisition Other drugs Low molecular weight heparinUnfractionated heparinBiospecimen Acquisition Anticoagulant CitrateEDTABiospecimen Aliquots and Components Blood and blood products PlasmaSerumWhole bloodBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Immunoassay Specific Technology platform ELISAHIPALFI-HITParticle gel immunoassay